Contract form Vanguard Research, 2-year grant: Comparison of a Long-acting Injectable Antipsychotic vs. Clinician’s Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics, funded by Otsuka Pharmaceutical Co., Ltd., $50,000, 2015‒2016.
National Institute on Drug Abuse Clinical Trials Network, California-Arizona Node, multi-year infrastructure grant (U10DA15815, subcontract from UCSF), $25,000‒$85,000/year, 2002‒present.
National Institute on Mental Health site, 1-year grant (1R44MH0940230‒1A1): IRT-based Self-report Screener for Prodromal Schizophrenia and Early Psychosis (PEP)—FastTrack, $123,000, 2012‒2013.
100 Pioneers for Smoking Cessation Virtual Leadership Academy, Phase II Award ($2,500), SAMHSA grant to UC San Francisco, 2010‒2011.
National Institute on Drug Abuse Clinical Trials Network, 2-year grant, CTN‒0046: Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes (U10DA15815, subcontract from UCSF), $319,000/year, 20092‒011.
100 Pioneers for Smoking Cessation Virtual Leadership Academy Award ($1,000), SAMHSA grant to UC San Francisco, 20092‒010.
National Institute on Drug Abuse Clinical Trials Network, 2-year grant, CTN0‒032: HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the United States (U10DA15815 – subcontract from UCSF), $395,000/year, 20082‒010.
Evaluation contract, Center for Mental Health Services, 4-year grant awarded to Jewish Family and Children’s Services of Southern Arizona (SAMHSA/NCTSN-TX U79 SM57216)—Children and Adolescent Traumatic Stress Services: A Multi-agency Collaboration, $72,000/year subcontract, 2004‒2009.
Evaluation contract, Center for Mental Health Services 2-year grant awarded to Jewish Family and Children’s Services of Southern Arizona (GFA#SM03‒005)—Tucson Coalition on Girls and Violence: A Multi-Agency Collaboration, $45,000/year subcontract, 2004‒2007.
Arizona Disease Control Research Commission 3-year grant (ID No. 7-039)—Comparing Smoking Cessation Treatments for Persons with Schizophrenia and Other Psychotic Disorders, $330,000 in direct costs, 2002‒2005.
Evaluation component, Center for Substance Abuse Prevention 3-year grant (UD1 SP09568)—Mentoring and Family Strengthening, $955,600 in direct costs, 2001‒2004.
Center for Substance Abuse Treatment 4-year grant (KD1 TI12539)—Evaluation of the ADMIRE Plus Program for Co-occurring Disorders, $1,050,000 in direct costs, 2000‒2004.
Pilot Program for Integrated Treatment Services for Seriously Mentally Ill Members with Co-occurring Substance Abuse Disorders, CSAT Grant to the Arizona Department of Behavioral Health Services through the Community Partnership of Southern Arizona, $150,000 in direct costs, 1999‒2000.
National Institute on Drug Abuse 5-year grant (R01‒DA08537)—Comparing Substance Abuse Treatments for Dual Diagnosis, $565,000 in direct costs, 1994‒1999.
Evaluation and Programmatic Contracts, La Frontera Mariachi Foundation Grant—Wellness Program for Women with Depression, 1993.
Evaluation contract, Arizona Governor’s Office of Drug Policy—Project Intervention: High Risk Youth Services Grant, Care‒I Quincy Douglas Project, 1993.